SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    C. Keijzer, B.J. Haijema, T. Meijerhof, P. Voorn, A. de Haan, K. Leenhouts, M.L. van Roosmalen, W. van Eden, F. Broere, Inactivated influenza vaccine adjuvanted with Bacterium-like particles induce systemic and mucosal influenza A virus specific T-cell and B-cell responses after nasal administration in a TLR2 dependent fashion, Vaccine, 2014,

    CrossRef

  2. 2
    Amabel C L Tan, Georgia Deliyannis, Mandvi Bharadwaj, Lorena E Brown, Weiguang Zeng, David C Jackson, The design and proof of concept for a CD8+ T cell-based vaccine inducing cross-subtype protection against influenza A virus, Immunology and Cell Biology, 2013, 91, 1, 96

    CrossRef

  3. 3
    Jodie McVernon, Terry Nolan, Panvax®: a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009, Expert Review of Vaccines, 2011, 10, 1, 35

    CrossRef

  4. 4
    Lorena E. Brown, The role of adjuvants in vaccines for seasonal and pandemic influenza, Vaccine, 2010, 28, 50, 8043

    CrossRef

  5. You have open access to this content5
    Alan W. Hampson, The ‘novel’ influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it?, Influenza and Other Respiratory Viruses, 2009, 3, 4